Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jan;117(1):156–160. doi: 10.1111/j.1476-5381.1996.tb15168.x

Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.

J Gonçalves 1, G Queiroz 1
PMCID: PMC1909367  PMID: 8825357

Abstract

1. The effects of analogues of adenosine and ATP on noradrenaline release elicited by electrical stimulation (5 Hz, 2700 pulses) were studied in superfused preparations of rat tail artery. The effects of purinoceptor antagonists, of adenosine deaminase and of adenosine uptake blockade were also examined. Noradrenaline was measured by h.p.l.c. electrochemical detection. 2. The A1-adenosine receptor agonist, N6-cyclopentyladenosine (CPA; 0.1-100 nM) reduced, whereas the A2A-receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680; 3-30 nM) increased evoked noradrenaline overflow. These effects were antagonized by the A1-adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 20 nM) and the A2-adenosine receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX; 100 nM), respectively. The P2Y-purinoceptor agonist, 2-methylthio-ATP (1-100 microM) reduced noradrenaline overflow, an effect prevented by the P2-purinoceptor antagonist, cibacron blue 3GA (100 microM) and suramin (100 microM). 3. Adenosine deaminase (2 u ml-1), DMPX (100 nM) and inhibition of adenosine uptake with S-(p-nitrobenzyl)-6-thioinosine (NBTI; 50 nM) decreased evoked noradrenaline overflow. DPCPX alone did not change noradrenaline overflow but prevented the inhibition caused by NBTI. The P2Y-purinoceptor antagonist, cibacron blue 3GA (100 microM) increased evoked noradrenaline overflow as did suramin, a non-selective P2-antagonist. 4. It is concluded that, in rat tail artery, inhibitory (A1 and P2Y) and facilitatory (A2A) purinoceptors are present and modulate noradrenaline release evoked by electrical stimulation. Endogenous purines tonically modulate noradrenaline release through activation of inhibitory P2Y and facilitatory A2A purinoceptors, whereas a tonic activation of inhibitory A1 purinoceptors seems to be prevented by adenosine uptake.

Full text

PDF
156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allgaier C., Hertting G., Kügelgen O. V. The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade. Br J Pharmacol. 1987 Feb;90(2):403–412. doi: 10.1111/j.1476-5381.1987.tb08970.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boland B., Himpens B., Vincent M. F., Gillis J. M., Casteels R. ATP activates P2x-contracting and P2y-relaxing purinoceptors in the smooth muscle of mouse vas deferens. Br J Pharmacol. 1992 Dec;107(4):1152–1158. doi: 10.1111/j.1476-5381.1992.tb13422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Daly J. W., Padgett W. L., Shamim M. T. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. J Med Chem. 1986 Jul;29(7):1305–1308. doi: 10.1021/jm00157a035. [DOI] [PubMed] [Google Scholar]
  4. Enero M. A., Saidman B. Q. Possible feed-back inhibition of noradrenaline release by purine compounds. Naunyn Schmiedebergs Arch Pharmacol. 1977 Mar;297(1):39–46. doi: 10.1007/BF00508808. [DOI] [PubMed] [Google Scholar]
  5. Forsyth K. M., Bjur R. A., Westfall D. P. Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens. J Pharmacol Exp Ther. 1991 Mar;256(3):821–826. [PubMed] [Google Scholar]
  6. Fuder H., Brink A., Meincke M., Tauber U. Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]noradrenaline release on rat iris. Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):417–423. doi: 10.1007/BF00176619. [DOI] [PubMed] [Google Scholar]
  7. Fuder H., Muth U. ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2y-like purinoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):352–357. doi: 10.1007/BF00171333. [DOI] [PubMed] [Google Scholar]
  8. Fujioka M., Cheung D. W. Autoregulation of neuromuscular transmission in the guinea-pig saphenous artery. Eur J Pharmacol. 1987 Jul 9;139(2):147–153. doi: 10.1016/0014-2999(87)90246-9. [DOI] [PubMed] [Google Scholar]
  9. Gonçalves J., Queiroz G. Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):367–371. doi: 10.1007/BF00171335. [DOI] [PubMed] [Google Scholar]
  10. Guimarães S., Paiva M. Q., Moura D., Vaz-da-Silva M. J., Albino-Teixeira A. Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters alpha 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec;350(6):692–695. doi: 10.1007/BF00169376. [DOI] [PubMed] [Google Scholar]
  11. Harms H. H., Wardeh G., Mulder A. H. Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex. Eur J Pharmacol. 1978 Jun 1;49(3):305–308. doi: 10.1016/0014-2999(78)90107-3. [DOI] [PubMed] [Google Scholar]
  12. Illes P., Rickmann H., Brod I., Bucher B., Stoclet J. C. Subsensitivity of presynaptic adenosine A1-receptors in caudal arteries of spontaneously hypertensive rats. Eur J Pharmacol. 1989 Dec 19;174(2-3):237–251. doi: 10.1016/0014-2999(89)90316-6. [DOI] [PubMed] [Google Scholar]
  13. Ishii R., Shinozuka K., Hattori K., Bjur R. A., Westfall D. P., Takeuchi K., Hashimoto T. Purinergic facilitation of norepinephrine release from adrenergic nerves of rabbit ear artery. Proc West Pharmacol Soc. 1993;36:17–20. [PubMed] [Google Scholar]
  14. Jarvis M. F., Schulz R., Hutchison A. J., Do U. H., Sills M. A., Williams M. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther. 1989 Dec;251(3):888–893. [PubMed] [Google Scholar]
  15. Kurz K., von Kügelgen I., Starke K. Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors. Br J Pharmacol. 1993 Dec;110(4):1465–1472. doi: 10.1111/j.1476-5381.1993.tb13986.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Limberger N., Späth L., Starke K. Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jul;338(1):53–61. doi: 10.1007/BF00168812. [DOI] [PubMed] [Google Scholar]
  17. Lupica C. R., Cass W. A., Zahniser N. R., Dunwiddie T. V. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther. 1990 Mar;252(3):1134–1141. [PubMed] [Google Scholar]
  18. Moos W. H., Szotek D. S., Bruns R. F. N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists. J Med Chem. 1985 Oct;28(10):1383–1384. doi: 10.1021/jm00148a001. [DOI] [PubMed] [Google Scholar]
  19. Olsson R. A., Pearson J. D. Cardiovascular purinoceptors. Physiol Rev. 1990 Jul;70(3):761–845. doi: 10.1152/physrev.1990.70.3.761. [DOI] [PubMed] [Google Scholar]
  20. Queiroz G., Gonçalves J., Carvalho F., Vale P. Electrically-evoked release of taurine in the rat vas deferens: evidence for a purinoceptor-mediated effect. Naunyn Schmiedebergs Arch Pharmacol. 1995 Jan;351(1):60–66. doi: 10.1007/BF00169065. [DOI] [PubMed] [Google Scholar]
  21. Sebastião A. M., Stone T. W., Ribeiro J. A. The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol. 1990 Oct;101(2):453–459. doi: 10.1111/j.1476-5381.1990.tb12729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shinozuka K., Bjur R. A., Westfall D. P. Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery. Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):221–227. doi: 10.1007/BF00173391. [DOI] [PubMed] [Google Scholar]
  23. Shinozuka K., Bjur R. A., Westfall D. P. Effects of alpha,beta-methylene ATP on the prejunctional purinoceptors of the sympathetic nerves of the rat caudal artery. J Pharmacol Exp Ther. 1990 Sep;254(3):900–904. [PubMed] [Google Scholar]
  24. Shirahase H., Usui H., Shimaji H., Kurahashi K., Fujiwara M. Endothelium-independent and endothelium-dependent contractions mediated by P2X- and P2Y-purinoceptors in canine basilar arteries. J Pharmacol Exp Ther. 1991 Feb;256(2):683–688. [PubMed] [Google Scholar]
  25. Soares-da-Silva P. Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels. Br J Pharmacol. 1988 Sep;95(1):218–224. doi: 10.1111/j.1476-5381.1988.tb16567.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Todorov L. D., Bjur R. A., Westfall D. P. Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. J Pharmacol Exp Ther. 1994 Feb;268(2):985–989. [PubMed] [Google Scholar]
  27. Tschöpl M., Harms L., Nörenberg W., Illes P. Excitatory effects of adenosine 5'-triphosphate on rat locus coeruleus neurones. Eur J Pharmacol. 1992 Mar 17;213(1):71–77. doi: 10.1016/0014-2999(92)90234-u. [DOI] [PubMed] [Google Scholar]
  28. Wiklund N. P., Cederqvist B., Gustafsson L. E. Adenosine enhancement of adrenergic neuroeffector transmission in guinea-pig pulmonary artery. Br J Pharmacol. 1989 Feb;96(2):425–433. doi: 10.1111/j.1476-5381.1989.tb11834.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Williams M., Braunwalder A., Erickson T. J. Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue. Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):179–183. doi: 10.1007/BF00511410. [DOI] [PubMed] [Google Scholar]
  30. Zhang G. L., Miyahara H., Suzuki H. Inhibitory actions of adenosine differ between ear and mesenteric arteries in the rabbit. Pflugers Arch. 1989 Oct;415(1):56–62. doi: 10.1007/BF00373141. [DOI] [PubMed] [Google Scholar]
  31. von Kügelgen I., Kurz K., Starke K. Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release. Neuroscience. 1993 Sep;56(2):263–267. doi: 10.1016/0306-4522(93)90330-i. [DOI] [PubMed] [Google Scholar]
  32. von Kügelgen I., Kurz K., Starke K. P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):125–132. doi: 10.1007/BF00169828. [DOI] [PubMed] [Google Scholar]
  33. von Kügelgen I., Schöffel E., Starke K. Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):522–532. doi: 10.1007/BF00260607. [DOI] [PubMed] [Google Scholar]
  34. von Kügelgen I., Späth L., Starke K. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br J Pharmacol. 1994 Nov;113(3):815–822. doi: 10.1111/j.1476-5381.1994.tb17066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. von Kügelgen I., Stoffel D., Starke K. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria. Br J Pharmacol. 1995 May;115(2):247–254. doi: 10.1111/j.1476-5381.1995.tb15870.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES